← Open Payments lookup

GARY WEICHBRODT: Open Payments

NPI 1538127261 · SMYRNA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$726 in 37 payments from 11 companies in 2025. Trend: 2023 $564 · 2024 $641 · 2025 $726

Food & beverage: $619Education: $107
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.9$154
Teva Pharmaceuticals USA, Inc.2$117
Janssen Pharmaceuticals, Inc5$94
ABBVIE INC.5$89
Supernus Pharmaceuticals, Inc.5$80
Vanda Pharmaceuticals Inc.3$49
Neurocrine BioSciences, Inc.2$42
Alkermes, Inc.2$38
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$30
Axsome Therapeutics, Inc.1$18

Products named: VRAYLAR, Qelbree, REXULTI, SPRAVATO, FANAPT, INGREZZA, ABILIFY MAINTENA, ABILIFY ASIMTUFII.

Industry payments across GA — which companies pay providers there.